ST诺泰 (688076.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

40.3x

EV/EBITDA

14.8x

Market Cap

CNY 8.60B

MomentumView details →

1D Return

−0.70%

YTD Return

—

RSI (14)

58.8

ValuationView details →

P/E (Fwd)

40.3x

EV/EBITDA

14.8x

Market Cap

CNY 8.60B

RSI (14)

58.8

MomentumView details →

1D Return

−0.70%

YTD Return

—

ProfitabilityView details →

Gross Margin

60.23%

Net Margin

16.02%

EBITDA Margin

37.43%

ROE (TTM)

9.93%

ROA (TTM)

4.54%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

+5.21%

EPS YoY

−39.40%

FCF YoY

+38.52%

Revenue CAGR 3Y

+43.95%

EPS CAGR 3Y

+20.89%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.27

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−12.96%

Capital & dividendView details →

Debt/Equity

0.76x

Current Ratio

1.17x

Quick Ratio

0.75x

Div Yield

1.22%

Div Rate

CNY 0.35

Div Growth 1Y

−38.75%

Financials snapshotView financials →

Revenue (TTM)

1.93B

Net Income (TTM)

309.27M

Op. CF (TTM)

683.73M

Next earningsOct 22, 2026 →

Latest newsMore news →

No recent news for 688076.SH.

Similar companies

CStone Pharmaceuticals02616.HK TG Therapeutics, Inc.TGTX ImmunityBio, Inc.IBRX Alphamab Oncology09966.HK Tennor Therap-b06872.HK 中源协和600645.SH Find similar companies →

Latest newsMore news →

No recent news for 688076.SH.